Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:38 AM ET 8-K
Clinical Trial Data Summit Therapeutics Inc. SMMT

Summit Therapeutics Clinical Trial Data

Summit Therapeutics' partner Akeso presented updated Phase III HARMONi-2 trial data showing ivonescimab monotherapy significantly improved overall survival compared to pembrolizumab in PD-L1-positive advanced NSCLC. Ivonescimab reduced the risk of death by 27% (HR 0.73) and improved median overall survival by 8.2 months (30.8 months vs 22.6 months).

Counterparty
Akeso Inc.
8:38 AM ET 8-K
M&A Deal Bowman Consulting Group Ltd. BWMN

Bowman Consulting Group Signs $1B M&A Deal with Bernhard Capital Partners

Bowman Consulting Group announced the expiration of the 35-day 'go-shop' period under its previously announced merger agreement with Bernhard Capital Partners. No alternative acquisition proposals were received during the solicitation period, and the company is now subject to 'no-shop' provisions. The all-cash transaction, valued at approximately $1.0 billion or $43.00 per share, is expected to close in the fourth quarter of 2026.

Value
$1B
Counterparty
Bernhard Capital Partners
8:37 AM ET 8-K
Bankruptcy & Restructuring Cambium Networks Corp CMBMF

Cambium Networks Bankruptcy & Restructuring

Cambium Networks' subsidiary, Cambium Networks, Ltd, has entered administration in the UK, with administrators appointed to sell assets or wind up the business. In connection with this insolvency, the company reduced its global workforce by 260 employees (53.6%) and terminated the role of Senior VP of Products, Vibhu Vivek.

Counterparty
RSM UK Restructuring Advisory LLP
8:35 AM ET 8-K
Business Update DeFi Development Corp. DFDV

DeFi Development Business Update

DeFi Development Corp. reported that its treasury holdings grew by 55,491 SOL to a total of 2,388,923 SOL and SOL equivalents as of September 11, 2026. The company also established a $300 million at-the-market (ATM) offering program for its Series C Perpetual Preferred Stock (CHAD) to fund future SOL purchases, though no shares have been sold yet. This update reflects the company's ongoing strategy to accumulate and compound Solana assets through its treasury infrastructure.

8:32 AM ET 8-K
Loan & Debt Eos Energy Enterprises, Inc. EOSE

Eos Energy Enterprises $87M Debt Financing with U.S. Department of Energy and Federal Financing Bank

Eos Energy Enterprises received an $87 million third loan advance under its existing $277.5 million loan guarantee agreement with the U.S. Department of Energy. The funding reimburses costs associated with the company's Thorn Hill manufacturing facility and supports the ramp-up of a second production line to reach 4 GWh of annual battery manufacturing capacity. This brings the total amount drawn under the DOE facility to approximately $178 million.

Value
$87M
Counterparty
U.S. Department of Energy (DOE) and Federal Financing Bank (FFB)
8:31 AM ET 8-K
Investor Presentation Bionano Genomics, Inc. BNGO

Bionano Genomics Investor Presentation

Bionano Genomics Chairman and Interim CEO Al Luderer is presenting at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026. The company filed its conference presentation deck as an exhibit, which includes updates on its business strategy, optical genome mapping (OGM) adoption, and cost-saving initiatives. The presentation also addresses the company's focus on extending its cash runway and reaching a pathway to profitability.

Counterparty
H.C. Wainwright
8:31 AM ET 8-K
Investor Presentation PennyMac Financial Services, Inc. PFSI

PennyMac Financial Services Investor Presentation

PennyMac Financial Services, Inc. filed an investor update presentation to be used at the Barclays Global Financial Services Conference. The presentation covers the company's strategic outlook, including its pending acquisition of Cenlar’s subservicing business and general market conditions.

Counterparty
Barclays
8:30 AM ET 8-K
Leadership Change Rimini Street, Inc. RMNI

Rimini Street Leadership Change

Rimini Street, Inc. announced the reinstatement of Steven Hershkowitz as Executive Vice President and Chief Revenue Officer, effective September 14, 2026. Mr. Hershkowitz resumes the same duties and responsibilities he held prior to his previously reported resignation on September 8, 2026, with his previous annual base salary of $480,000 and incentive opportunity of $320,000.16 restored.

8:30 AM ET 8-K
Leadership Change Graco Inc GGG

Graco Leadership Change

Graco Inc. has appointed Richard B. Lewis to its Board of Directors and Audit Committee, effective December 3, 2026. Mr. Lewis currently serves as the President and CEO of Donaldson Company, Inc. and will receive Graco's standard non-employee director compensation.

Counterparty
Richard B. Lewis
8:27 AM ET 8-K
Capital Raise Enbridge Inc ENB

Enbridge Capital Raise

Enbridge Inc. completed a bought deal public offering of 44,735,000 common shares, including the full exercise of an over-allotment option. The offering generated gross proceeds of approximately CDN$3.0 billion. The transaction was conducted through a syndicate of underwriters led by RBC Dominion Securities and CIBC World Markets.

Counterparty
RBC Dominion Securities Inc. and CIBC World Market Inc.
8:12 AM ET 8-K
Investor Presentation Netstreit Corp. NTST

Netstreit Investor Presentation

NETSTREIT Corp. released a formal investor presentation on September 14, 2026, which management intends to use for upcoming meetings with investors. The presentation covers the company's business and growth strategies, investment activities, and trends in the single-tenant retail commercial real estate market.

8:11 AM ET 8-K
M&A Deal Nomadar Corp. NOMA

Nomadar Signs $2M M&A Deal with Fox Soccer Academy

Nomadar Corp. has entered into a definitive equity purchase agreement to acquire a majority interest in Fox Soccer Academy (FSA), which operates youth soccer programs in New York, North Carolina, the UK, and Austria. The consideration includes a $2 million base cash payment and the issuance of Class B Units in a subsidiary representing a 49% retained interest by the sellers. The deal expands Nomadar's international sports development platform by integrating FSA's Premier League-inspired curriculum with Nomadar's existing Spanish football initiatives.

Value
$2M
Counterparty
Fox Soccer Academy
8:09 AM ET 8-K
Financial Results R F Industries Ltd RFIL

R F Industries Financial Results

RF Industries reported record third-quarter fiscal 2026 net sales of $23.96 million, a 21% year-over-year increase. Net income rose 267% to $1.44 million, or $0.12 per diluted share, driven by a shift toward higher-value custom cabling and integrated systems solutions. The company ended the quarter with a backlog of $18.6 million and reported significant margin expansion to 35.6%.

Term
Q3 2026
Earnings call
Sep 14, 2026, 8:30 AM ET

“The RFI team delivered another quarter of accelerating topline growth by converting stronger demand into expanding margins and dramatically higher profitability, as well as demonstrating the earnings power of the business as revenue scales above the $20 million quarterly run rate.”

Robert Dawson, Chief Executive Officer of RF Industries

“Our steady margin expansion is a direct result of successfully executing a multi-year mix shift toward higher-value solutions, including our custom cabling and integrated systems offerings. These solutions have more engineering content, larger project scope, and engender stronger customer relationships than traditional component sales.”

Robert Dawson, Chief Executive Officer of RF Industries
8:06 AM ET 8-K
Deal Termination Medicus Pharma Ltd. MDCX

Medicus Pharma Deal Termination with Ya II Pn, Ltd.

Medicus Pharma Ltd. and Yorkville mutually agreed to terminate their $15.0 million Standby Equity Purchase Agreement (SEPA) effective September 11, 2026. At the time of termination, no shares had been issued and no borrowings were outstanding under the facility, with no fees due from either party.

Counterparty
YA II PN, LTD.
8:03 AM ET 8-K
Clinical Trial Data Definium Therapeutics, Inc. DFTX

Definium Therapeutics Clinical Trial Data

Definium Therapeutics announced positive topline results from its Phase 3 Panorama study of DT120 ODT for the treatment of generalized anxiety disorder (GAD). The study met its primary endpoint with a statistically significant reduction in HAM-A scores compared to placebo (p<0.0001) and was generally well tolerated. The company plans to file an NDA in the first half of 2027 following a pre-NDA meeting with the FDA in Q4 2026.

8:02 AM ET 8-K
Divestiture Thryv Holdings, Inc. THRY

Thryv Holdings Divestiture to Coldwater YP, LLC for $142M

Thryv Holdings, Inc. has entered into a definitive agreement to sell its print directories business in the U.S., Australia, and New Zealand to Coldwater YP, LLC for $142 million in cash. The company intends to use the proceeds to reduce debt and focus resources on its AI-powered SaaS Growth Platform. The transaction is expected to close in the fourth quarter of 2026.

Value
$142M
Counterparty
Coldwater YP, LLC (an affiliate of Carolwood, L.P.)
8:02 AM ET 8-K
Loan & Debt Piedmont Realty Trust, Inc. PDM

Piedmont Realty Trust $200M Debt Financing with Piedmont Operating Partnership, LP

Piedmont Realty Trust announced a proposed private offering of $200 million in exchangeable senior notes due 2031 by its operating partnership. The notes will be senior unsecured obligations guaranteed by the company, with an additional $30 million overallotment option for initial purchasers. The filing also updated investors on recent activity, including the $52.7 million acquisition of an office building in Arlington, VA, and the $12 million sale of land in Dallas.

Value
$200M
Counterparty
Piedmont Operating Partnership, LP
Term
through Feb 2031
8:01 AM ET 8-K
Investor Presentation DarkHorse Technologies Inc. DRK

Sphere 3D Investor Presentation

Sphere 3D Corp. (doing business as DarkHorse Technologies) furnished a formal investor presentation detailing its strategic shift toward AI infrastructure and high-performance computing. The presentation outlines several planned and operating sites, including Blackjack, Rockwood, Brickyard, and Truckstop, with a total planned power capacity of approximately 105 MW.

8:01 AM ET 8-K
Capital Raise Cabaletta Bio, Inc. CABA

Cabaletta Bio Capital Raise of $128M

Cabaletta Bio announced the completion of warrant exercises from its June 2025 public offering, resulting in total aggregate gross proceeds of approximately $128.2 million. The warrants, which had an exercise price of $2.50 per share, expired on September 12, 2026, with the vast majority of exercises occurring between July 1, 2026, and the expiration date.

Value
$128M
8:01 AM ET 8-K
M&A Deal Perdoceo Education Corp PRDO

Perdoceo Education Signs $224M M&A Deal with South University Savannah, LLC

Perdoceo Education Corporation entered into a definitive agreement to acquire 100% of South University for an initial cash payment of $150 million, plus $18 million in deferred consideration and up to $56 million in performance-based earn-outs. South University is a leading health sciences-focused institution with 11 campus locations and approximately 10,500 students, generating $291 million in 2025 revenue. The transaction is expected to close as early as April 2027 and will expand Perdoceo's graduate health sciences and academic program offerings.

Value
$224M
Counterparty
South University Savannah, LLC
8:01 AM ET 8-K
Clinical Trial Data Telomir Pharmaceuticals, Inc. TELO

Telomir Pharmaceuticals Clinical Trial Data

Telomir Pharmaceuticals announced positive preclinical in-vitro research findings demonstrating that its compound Telomir-Zn inhibited cell growth in both human and canine osteosarcoma models. The study, conducted with The Ohio State University, showed consistent anti-tumor activity at low drug concentrations, supporting a potential parallel development pathway for veterinary and human oncology indications.

Counterparty
The Ohio State University College of Veterinary Medicine
8:01 AM ET 8-K
Loan & Debt Western Digital Corp WDC

Western Digital $110M Debt Financing with U.S. Bank Trust Company, National Association

Western Digital Corporation has issued a notice to redeem all $109.505 million of its outstanding 3.00% Convertible Senior Notes due 2028 on November 16, 2026. The company expects most holders to convert their notes into a combination of cash and common stock prior to the redemption date at a rate of 26.5231 shares per $1,000 principal amount. This action allows the company to settle the debt obligation and simplify its capital structure.

Value
$110M
Counterparty
U.S. Bank Trust Company, National Association
8:01 AM ET Form 4
Insider Buying Dominari Holdings Inc. DOMH

Dominari Holdings President Kyle Michael Wool Buys $209K of Stock

Kyle Michael Wool, President, bought 100,000 shares of Dominari Holdings Inc. at $2.02 to $2.16 a share (average $2.09) in 2 transactions, worth $209K in total between Sep 10, 2026 and Sep 11, 2026. Shares held after the trade: 4,311,828 (+1.2%).

Value
$209K
Shares
100,000
Average price
$2.09
Role
President
Holding change
+1.2%
Trade date
Sep 10, 2026 to Sep 11, 2026
8:01 AM ET Form 4
Insider Buying Dominari Holdings Inc. DOMH

Dominari Holdings CEO Anthony Hayes Buys $209K of Stock

Anthony Hayes, CEO, bought 100,000 shares of Dominari Holdings Inc. at $2.02 to $2.16 a share (average $2.09) in 2 transactions, worth $209K in total between Sep 10, 2026 and Sep 11, 2026. Shares held after the trade: 4,600,873 (+1.1%).

Value
$209K
Shares
100,000
Average price
$2.09
Role
CEO
Holding change
+1.1%
Trade date
Sep 10, 2026 to Sep 11, 2026
8:01 AM ET 8-K
Regulatory Approval Scholar Rock Holding Corp SRRK

Scholar Rock Holding Regulatory Approval

Scholar Rock received FDA approval for ISEMBYLD (apitegromab-mstn) for the treatment of spinal muscular atrophy (SMA) in adults and children aged 2 and older. This marks the first and only muscle-targeted treatment approved for SMA, representing a significant therapeutic breakthrough for the company's myostatin biology platform.

Earnings call
Sep 14, 2026, 8:00 AM ET

“Today’s FDA approval of ISEMBYLD marks a defining moment for the SMA community as we now launch the world’s first-ever muscle targeted treatment for children and adults living with SMA in the U.S. After decades of failed industry-wide efforts to unlock the potential of myostatin inhibition, Scholar Rock has delivered a therapeutic breakthrough with ISEMBYLD.”

David L. Hallal, Chairman and Chief Executive Officer of Scholar Rock
8:00 AM ET 8-K
Stock Buyback Strategy Inc MSTR

Strategy Announces $139M Stock Buyback

Strategy Inc repurchased 1,420,467 shares of its Variable Rate Series A Perpetual Stretch Preferred Stock (STRC) for an aggregate price of $139.3 million. As of September 13, 2026, the company maintains a bitcoin treasury of approximately 845,050 BTC and has $2.05 billion in remaining authorization across its preferred and common stock repurchase programs.

Value
$139M
Term
September 8, 2026 to September 13, 2026
7:59 AM ET 8-K
Business Update Strive, Inc. ASST

Strive Business Update

Strive, Inc. provided an operational update disclosing the purchase of 469 bitcoin between September 8 and September 11, 2026, at an average price of $77,954 per coin. The company reported its total bitcoin holdings reached 25,000 as of September 11, 2026, alongside updates to its cash position and share count metrics.

7:59 AM ET 8-K
M&A Deal AirJoule Technologies Corp. AIRJ

AirJoule Technologies Signs $27M M&A Deal with Bitsink LLC

AirJoule Technologies acquired 100% of Bitsink LLC, a manufacturer of cooling and power infrastructure for AI and high-density data centers, for $18 million in cash and $9 million in common stock. The deal includes up to $40 million in additional performance-based earnout payments through 2029, significantly expanding AirJoule's footprint in the AI and HPC infrastructure market.

Value
$27M
Counterparty
Bitsink LLC
Earnings call
Sep 14, 2026, 8:30 AM ET

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.